Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- article scientifique publié en 2005 (fr)
- наукова стаття, опублікована в жовтні 2005 (uk)
- scientific article published on 19 October 2005 (en)
- artículu científicu espublizáu n'ochobre de 2005 (ast)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Tuula Salo
- Ylermi Soini
- Jani Oiva
- Antti Nissinen
- Kariylitalo
|
rdfs:label
| - Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (en)
- Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (nl)
|
skos:prefLabel
| - Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (en)
- Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (nl)
|
name
| - Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (en)
- Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (nl)
|
author
| |
author
| |
title
| |
title
| - Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| - 10.1016/J.IJCARD.2005.07.042
|
is about
of | |
is cites work
of | |
is cites work
of | |